Suicide is the 10th leading cause of death in the U.S. Medical providers often do not detect the suicidal ideation of their patients, even though most of these patients receive health care services in the year prior to the attempt or suicide. Unfortunately, clinician assessments can be extremely costly and time-consuming, and require face-to-face interaction. For these reasons, standardized risk assessment tools play a crucial role in identifying at-risk patients. Current assessment tools, however, are not validated for identifying those at risk of imminent suicide. Moreover, these assessments typically require extensive training to conduct the assessment and to interpret the results. Voi Detect is a HIPAA-compliant product that delivers the digitized Systematic Expert Risk Assessment for Suicide (SERAS). SERAS is the only validated suicide risk assessment designed to detect near-term risk (next 72 hours). SERAS replicates the âgold standardâ? of the decision making of a psychiatrist. SERAS has low face validity, as well as accurate sensitivity and specificity around classifying near-term suicide risk. Based on its unique scoring algorithm, SERAS is also able to improve its predictive capabilities over time. Finally, SERAS can be administered by non-clinicians, be given remotely, and takes less than two minutes to complete.
